The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors

Long/Short Equities & Deep Value/Contrarian Investing Report

May 02, 2011

Buy ($175)

Topics covered: Undercovered Small-cap Stocks, Deep-value Philosophy, Conservative Long/Short Investing

Companies covered: International Business Machines Corporation (NYSE:IBM), General Motors Company (NYSE:GM), Verizon Communications Inc. (NYSE:VZ), PowerSecure International, Inc (NYSE:POWR), OGE Energy Corporation (NYSE:OGE), Frontier Communications Corporation (NASDAQ:FTR), Caterpillar, Inc. (NYSE:CAT)

The Endowment Model Of Investing - Mark W. Yusko - Morgan Creek Capital Management Llc
Mark W. Yusko
A Deep-value Approach To Fixed Income Investing - Tom Siderewicz - Century Management
Small-cap Contrarian Investing Strategies - Michael C. Heaberg - Axiom Asset Management
Michael C. Heaberg
Conservative Long/short Investing - Michael Shinnick - Wasatch Funds
Michael Shinnick
Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: Pasithea Therapeutics Corp. (NASDAQ:KTTA)
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
AI Opportunities Expand to Industrial, Utilities and Energy Sectors
India Fund Manager Expects Discretionary Spending to Grow
Inefficiency in Ex-US Markets Creates Opportunity to Buy at a Discount
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy